Gsk Share Discussion Threads

[tradermichael] 26/4/2023 11:35

They were reduced only as a result of the split.

[lippy4] 26/4/2023 11:33

the trouble is trader they are getting less..

[spacecake] 26/4/2023 11:21

GSK need to have a chat with the plain English campaign - how to write reports that people can read and understand. All those references to covid-19 business gives me a headache.

[tradermichael] 26/4/2023 10:55

Just keep taking the dividends ..... ;0)

[halfpenny] 26/4/2023 10:44

GSK now likely to go above 1500 as Litigation will be a massive positive outcome.

Happy Days Ahead

[tradermichael] 26/4/2023 09:57

Dividend amount released today in Q1 results. FY 56.5 equates to 3.8% yield at today's price.

[montyhedge] 26/4/2023 09:52

Is that right with the dividend mentioned yield 3.8%.

[tradermichael] 26/4/2023 09:43

Apart from this, you mean?:::

Full-year 2023 guidance affirmed. Dividend of 14p declared for Q1 2023. 56.5p expected for the full-year 2023.

Innovative pipeline of 68 vaccines and specialty medicines based on the science of immune system with 17 in Phase III/registration; four anticipated 2023 approvals (daprodustat in anaemia due to chronic kidney disease, RSV older adults vaccine, momelotinib in myelofibrosis and Jemperli in first-line endometrial cancer).

Four positive phase III/IV data readouts in Q1 2023, including pentavalent Meningitis ABCWY vaccine candidate; gepotidacin for uncomplicated urinary tract infections; Jemperli for first-line endometrial cancer and Cabenuva for HIV treatment.

[spoole5] 26/4/2023 09:42

Let's see how much damage she can do!

[tradermichael] 26/4/2023 09:38

Register for the live webcast today with Emma, and other members of her team at 12:00 BST, 07:00 EDT.

[patientcapital] 26/4/2023 09:38

Alp., are you raising this as a potential problem or more as a technical query?

[mj19] 26/4/2023 09:07

GSK, a pharmaceutical group, announced that 1Q adjusted EPS rose 15% on year to 37.0 pence while revenue dropped 8% at constant exchange rates to 6.95 billion pounds.

[spoole5] 26/4/2023 08:45

Same old gsk on results day. Is Emma gonna speak, that will knock another 30p off!

[alphorn] 26/4/2023 08:34

Patient - the long term question is when a holding company is in country x (GSK is UK) and the bulk of the earnings are in countries a,b,c how does the holding company pay out dividends? It will need to borrow or repatriate foreign earnings. Is that an issue??? (An AGM question for someone).

[patientcapital] 26/4/2023 08:23

Regarding cash outflow there was also this comment:"Free cash outflow was GBP689 million for the quarter (Q1 2022: GBP1,477 million inflow). The decrease primarily reflected an unfavourable comparison due to the upfront income from the settlement with Gilead received in Q1 2022, unfavourable timing of profit share payments for Xevudy, increase in seasonal inventory, lower payable balances reflecting increased investment in 2022 and higher tax payments."

[alphorn] 26/4/2023 08:19

Results look okish. Two observations:
- Intangibles sitting there at £21bn. Will increase with further acquisitions.
- Net debt increased by £0.8bn "primarily due to £0.7bn free cash outflow and dividends paid to shareholders".

[supermarky] 26/4/2023 08:07

Looks good to me but that doesn't mean the news will be positively perceived by the market.

[igoe104] 26/4/2023 07:24

Big beat on results, excellent..

Estimates were for 33.2p but they have come in at 37p. 👌

Hopefully smash though £15 today and head towards £16...

Shorters are going to be worried 😟

[njdlucas] 25/4/2023 20:57

@PC Have you ever heard about commas?

[patientcapital] 25/4/2023 20:24

I don't think it is providing patient confidentiality is maintained. A good idea even if it isn't a new one.

[alphorn] 25/4/2023 15:22

Big pharma wants NHS data: GSK boss asks Rishi Sunak to allow drug firms to see treasure trove of medical records in bid to find new treatments.

A big discussion!

[patientcapital] 25/4/2023 14:14

More than I should say.

[tradermichael] 25/4/2023 13:30

I don't recall the article having been posted, thanks. It reinforces what many believe in that a worst-case scenario has likely been priced into the share (re. litigation).

[rikky72] 25/4/2023 13:14

Not sure if this has already been posted:https://www.proactiveinvestors.co.uk/companies/news/1011883/gsk-growth-outlook-being-overlooked-due-to-zantac-concerns-1011883.html